CUV 1.35% $14.60 clinuvel pharmaceuticals limited

2024 Catalyst Countdown, page-25

  1. 712 Posts.
    lightbulb Created with Sketch. 199
    CUV has been relatively slow in their product launch to market. Even Scenesse for EPP (outside USA) appears a tad slow. Pricing is an issue clearly. OTC products 2 and 3 are targeting ‘natural tanning’ and skin cancer. MT2 is unregulated and not only not registered for use through the TGA but actively warned against due to lack of regulated trials and side effects. Not sure about the angst - you can quite easily secure MT2 if you want it. To access Clinuvel’s products you have to wait a bit and pay a lot more (such is the cost of regulated development).
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.60
Change
-0.200(1.35%)
Mkt cap ! $731.5M
Open High Low Value Volume
$14.64 $14.85 $14.58 $346.2K 23.56K

Buyers (Bids)

No. Vol. Price($)
1 89 $14.58
 

Sellers (Offers)

Price($) Vol. No.
$14.65 80 1
View Market Depth
Last trade - 16.10pm 17/06/2024 (20 minute delay) ?
Last
$14.58
  Change
-0.200 ( 2.07 %)
Open High Low Volume
$14.66 $14.86 $14.58 2914
Last updated 15.59pm 17/06/2024 ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.